130 related articles for article (PubMed ID: 7724539)
1. Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.
Naffakh N; Henri A; Villeval JL; Rouyer-Fessard P; Moullier P; Blumenfeld N; Danos O; Vainchenker W; Heard JM; Beuzard Y
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3194-8. PubMed ID: 7724539
[TBL] [Abstract][Full Text] [Related]
2. Modulation of erythropoietin delivery from engineered muscles in mice.
Bohl D; Heard JM
Hum Gene Ther; 1997 Jan; 8(2):195-204. PubMed ID: 9017423
[TBL] [Abstract][Full Text] [Related]
3. Organoids direct systemic expression of erythropoietin in mice.
Descamps V; Blumenfeld N; Perricaudet M; Beuzard Y; Kremer EJ
Gene Ther; 1995 Aug; 2(6):411-7. PubMed ID: 7584116
[TBL] [Abstract][Full Text] [Related]
4. Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy.
Schwenter F; Déglon N; Aebischer P
J Gene Med; 2003 Mar; 5(3):246-57. PubMed ID: 12666190
[TBL] [Abstract][Full Text] [Related]
5. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs.
Salvetti A; Moullier P; Cornet V; Brooks D; Hopwood JJ; Danos O; Heard JM
Hum Gene Ther; 1995 Sep; 6(9):1153-9. PubMed ID: 8527473
[TBL] [Abstract][Full Text] [Related]
6. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
[TBL] [Abstract][Full Text] [Related]
7. A self-immunomodulating myoblast cell line for erythropoietin delivery.
Schneider BL; Peduto G; Aebischer P
Gene Ther; 2001 Jan; 8(1):58-66. PubMed ID: 11402302
[TBL] [Abstract][Full Text] [Related]
8. The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblasts.
Scheidemann F; Löser M; Niedermeier A; Kromminga A; Therrien JP; Vogel J; Pfützner W
Exp Dermatol; 2008 Jun; 17(6):481-8. PubMed ID: 18331333
[TBL] [Abstract][Full Text] [Related]
9. Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells.
Serguera C; Bohl D; Rolland E; Prevost P; Heard JM
Hum Gene Ther; 1999 Feb; 10(3):375-83. PubMed ID: 10048390
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for long-term expression of erythropoietin in rats.
Osborne WR; Ramesh N; Lau S; Clowes MM; Dale DC; Clowes AW
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8055-8. PubMed ID: 7644537
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta-thalassemia.
Villeval JL; Rouyer-Fessard P; Blumenfeld N; Henri A; Vainchenker W; Beuzard Y
Blood; 1994 Aug; 84(3):928-33. PubMed ID: 8043875
[TBL] [Abstract][Full Text] [Related]
12. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.
Hamamori Y; Samal B; Tian J; Kedes L
J Clin Invest; 1995 Apr; 95(4):1808-13. PubMed ID: 7706487
[TBL] [Abstract][Full Text] [Related]
13. Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA.
Hamamori Y; Samal B; Tian J; Kedes L
Hum Gene Ther; 1994 Nov; 5(11):1349-56. PubMed ID: 7893806
[TBL] [Abstract][Full Text] [Related]
14. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells.
Eliopoulos N; Lejeune L; Martineau D; Galipeau J
Mol Ther; 2004 Oct; 10(4):741-8. PubMed ID: 15451458
[TBL] [Abstract][Full Text] [Related]
15. Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts.
Moullier P; Maréchal V; Danos O; Heard JM
Transplantation; 1993 Aug; 56(2):427-32. PubMed ID: 8356601
[TBL] [Abstract][Full Text] [Related]
16. Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts.
Sommer B; Rinsch C; Payen E; Dalle B; Schneider B; Déglon N; Henri A; Beuzard Y; Aebischer P
Mol Ther; 2002 Aug; 6(2):155-61. PubMed ID: 12161181
[TBL] [Abstract][Full Text] [Related]
17. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector.
Svensson EC; Black HB; Dugger DL; Tripathy SK; Goldwasser E; Hao Z; Chu L; Leiden JM
Hum Gene Ther; 1997 Oct; 8(15):1797-806. PubMed ID: 9358029
[TBL] [Abstract][Full Text] [Related]
18. Establishment of transgenic fibroblasts for producing recombinant human interferon-α and erythropoietin in bovine milk.
Jung EM; An BS; Kim YK; Hwang I; Lee JY; Shin TY; Hyun SH; Hwang WS; Jeung EB
Mol Med Rep; 2013 Feb; 7(2):406-12. PubMed ID: 23151730
[TBL] [Abstract][Full Text] [Related]
19. Sustainable systemic delivery via a single injection of lentivirus into human skin tissue.
Baek SC; Lin Q; Robbins PB; Fan H; Khavari PA
Hum Gene Ther; 2001 Aug; 12(12):1551-8. PubMed ID: 11506697
[TBL] [Abstract][Full Text] [Related]
20. Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo.
Dalle B; Henri A; Rouyer-Fessard P; Bettan M; Scherman D; Beuzard Y; Payen E
Blood; 2001 Jun; 97(12):3776-82. PubMed ID: 11389016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
